US$ 24.70
sitagliptin glp 1 agonist GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Mechanism of action of sitagliptin,
Description
L., Khalid, U., ONeil, P

Estimates of cardiometabolic marker changes after treatment cessation are based on modeled projections of observed trends, with limited long-term follow-up

Similar content being viewed by others Introduction Dipeptidyl peptidase 4 (DPP-4) is a serine peptidase found in the form of a surface protein anchored to the cell membrane or soluble in plasma

The results from these studies are presented in Table 4

Kunutsor SK, Seidu BS, Seidu S
